These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of botulinum toxin type a in the acute phase of facial nerve injury after neurosurgical surgery. Orlova OR; Akulov MA; Usachev DI; Taniashin SV; Zakharov VO; Saksonova EV; Mingazova LR; Surovykh SV Zh Vopr Neirokhir Im N N Burdenko; 2014; 78(6):50-54. PubMed ID: 25809169 [TBL] [Abstract][Full Text] [Related]
3. Platysma synkinesis in facial palsy and botulinum toxin type A. Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160 [TBL] [Abstract][Full Text] [Related]
4. Effect of 3 Commercially Available Botulinum Toxin Neuromodulators on Facial Synkinesis: A Randomized Clinical Trial. Thomas AJ; Larson MO; Braden S; Cannon RB; Ward PD JAMA Facial Plast Surg; 2018 Mar; 20(2):141-147. PubMed ID: 28973094 [TBL] [Abstract][Full Text] [Related]
5. Long-term facial improvement after repeated BoNT-A injections and mirror biofeedback exercises for chronic facial synkinesis: a case-series study. Mandrini S; Comelli M; Dall'angelo A; Togni R; Cecini M; Pavese C; Dalla Toffola E Eur J Phys Rehabil Med; 2016 Dec; 52(6):810-818. PubMed ID: 27164539 [TBL] [Abstract][Full Text] [Related]
6. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis. Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443 [TBL] [Abstract][Full Text] [Related]
7. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046 [TBL] [Abstract][Full Text] [Related]
8. [Facial nerve injury in neurosurgery: a rehabilitation potential of botulinum therapy]. Akulov MA; Orlova OR; Tabashnikova TV; Karnaukhov VV; Orlova AS Zh Vopr Neirokhir Im N N Burdenko; 2018; 82(1):111-118. PubMed ID: 29543223 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients. Terzis JK; Karypidis D J Plast Reconstr Aesthet Surg; 2012 Aug; 65(8):1009-18. PubMed ID: 22483723 [TBL] [Abstract][Full Text] [Related]
10. Treating Buccinator With Botulinum Toxin in Patients With Facial Synkinesis: A Previously Overlooked Target. Wei LA; Diels J; Lucarelli MJ Ophthalmic Plast Reconstr Surg; 2016; 32(2):138-41. PubMed ID: 26325382 [TBL] [Abstract][Full Text] [Related]
11. Epidemiologic Overview of Synkinesis in 353 Patients with Longstanding Facial Paralysis under Treatment with Botulinum Toxin for 11 Years. Salles AG; da Costa EF; Ferreira MC; do Nascimento Remigio AF; Moraes LB; Gemperli R Plast Reconstr Surg; 2015 Dec; 136(6):1289-1298. PubMed ID: 26595022 [TBL] [Abstract][Full Text] [Related]
12. [Facial palsy sequel and botulinum toxin]. Benichou L; Labbe D; Le Louarn C; Guerreschi P Ann Chir Plast Esthet; 2015 Oct; 60(5):377-92. PubMed ID: 26432177 [TBL] [Abstract][Full Text] [Related]
13. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A. McElhinny ER; Reich I; Burt B; Mancini R; Wladis EJ; Durairaj VD; Shinder R Ophthalmic Plast Reconstr Surg; 2013; 29(3):175-8. PubMed ID: 23467287 [TBL] [Abstract][Full Text] [Related]
14. Long-Term Changes in the Treatment Pattern of Botulinum Toxin A Injections for Postfacial Paralysis Synkinesis Following Modified Selective Neurectomy. Hjelm N; Crippen M; Azizzadeh B Facial Plast Surg Aesthet Med; 2021; 23(3):234-235. PubMed ID: 33306003 [No Abstract] [Full Text] [Related]
15. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis. Choi KH; Rho SH; Lee JM; Jeon JH; Park SY; Kim J J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):1058-63. PubMed ID: 23683725 [TBL] [Abstract][Full Text] [Related]
16. Quantitative measurement of evolution of postparetic ocular synkinesis treated with botulinum toxin type A. Cecini M; Pavese C; Comelli M; Carlisi E; Sala V; Bejor M; Toffola ED Plast Reconstr Surg; 2013 Nov; 132(5):1255-1264. PubMed ID: 24165606 [TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis. Filipo R; Spahiu I; Covelli E; Nicastri M; Bertoli GA Laryngoscope; 2012 Feb; 122(2):266-70. PubMed ID: 22252570 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis. Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100 [TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin treatment of the buccinator muscle facial synkinesis: A systematic review. de Jongh FW; Wolf O; Wong ZY; Ingels KJAO; Pouwels S J Plast Reconstr Aesthet Surg; 2023 Nov; 86():88-93. PubMed ID: 37716254 [TBL] [Abstract][Full Text] [Related]
20. Combined protocol for treatment of secondary effects from facial nerve palsy. Monini S; De Carlo A; Biagini M; Buffoni A; Volpini L; Lazzarino AI; Barbara M Acta Otolaryngol; 2011 Aug; 131(8):882-6. PubMed ID: 21534714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]